FI956353L - Farmaceutiska kompositioner och deras användning speciellt för behandling av neurodegenerativa sjukdomar - Google Patents
Farmaceutiska kompositioner och deras användning speciellt för behandling av neurodegenerativa sjukdomar Download PDFInfo
- Publication number
- FI956353L FI956353L FI956353A FI956353A FI956353L FI 956353 L FI956353 L FI 956353L FI 956353 A FI956353 A FI 956353A FI 956353 A FI956353 A FI 956353A FI 956353 L FI956353 L FI 956353L
- Authority
- FI
- Finland
- Prior art keywords
- treatment
- pharmaceutical preparations
- neurodegenerative diseases
- neurodegenerative
- diseases
- Prior art date
Links
- 230000004770 neurodegeneration Effects 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/13—Decoys
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9307962A FR2707880B1 (fr) | 1993-06-30 | 1993-06-30 | Compositions pharmaceutiques et leur utilisation, notamment pour le traitement des maladies neurodégénératives. |
| FR9307962 | 1993-06-30 | ||
| FR9400771 | 1994-01-25 | ||
| PCT/FR1994/000771 WO1995001429A1 (fr) | 1993-06-30 | 1994-06-27 | Compositions pharmaceutiques et leur utilisation, notamment pour le traitement des maladies neurodegeneratives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI956353L true FI956353L (sv) | 1995-12-29 |
| FI956353A0 FI956353A0 (sv) | 1995-12-29 |
| FI120942B FI120942B (sv) | 2010-05-14 |
Family
ID=9448720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI956353A FI120942B (sv) | 1993-06-30 | 1995-12-29 | Förfarande för framställning av en dubbeltrådig nukleinsyra |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6140112A (sv) |
| EP (2) | EP0707644B1 (sv) |
| JP (1) | JP3755825B2 (sv) |
| KR (1) | KR100517879B1 (sv) |
| AT (1) | ATE276360T1 (sv) |
| AU (1) | AU696644B2 (sv) |
| CA (1) | CA2166318C (sv) |
| DE (1) | DE69433996T2 (sv) |
| DK (1) | DK0707644T3 (sv) |
| ES (1) | ES2227528T3 (sv) |
| FI (1) | FI120942B (sv) |
| FR (1) | FR2707880B1 (sv) |
| NO (1) | NO321455B1 (sv) |
| PT (1) | PT707644E (sv) |
| WO (1) | WO1995001429A1 (sv) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6017903A (en) | 1996-09-27 | 2000-01-25 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors |
| US5824662A (en) | 1996-09-27 | 1998-10-20 | Guilford Pharmaceuticals Inc. | Treatment of global and focal ischemia using naaladase inhibitors |
| NZ334780A (en) | 1996-09-27 | 2000-12-22 | Guilford Pharm Inc | Use of a NAALADase inhibitor for treating glutamate abnormality and effecting neuronal activity in animals |
| US6599741B1 (en) | 1999-09-14 | 2003-07-29 | Avontec Gmbh | Modulating transcription of genes in vascular cells |
| DE29916160U1 (de) | 1999-09-14 | 2000-03-09 | Cardiogene Gentherapeutische Systeme AG, 40699 Erkrath | Modulation der Transkription von Genen in vaskulären Zellen |
| CN1315402A (zh) * | 2000-03-28 | 2001-10-03 | 上海博德基因开发有限公司 | 一种新的多肽——人淀粉类前体蛋白结合蛋白14和编码这种多肽的多核苷酸 |
| CN1315439A (zh) * | 2000-03-29 | 2001-10-03 | 上海博德基因开发有限公司 | 一种新的多肽——人淀粉类前体蛋白结合蛋白9和编码这种多肽的多核苷酸 |
| DE10308045B3 (de) | 2003-02-26 | 2004-06-17 | Lurgi Ag | Verfahren und Vorrichtung zur kontinuierlichen Gewinnung freier Weinsäure aus Kaliumhydrogentartrat enthaltenden Rohstoffen |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2573436B1 (fr) * | 1984-11-20 | 1989-02-17 | Pasteur Institut | Adn recombinant comportant une sequence nucleotidique codant pour un polypeptide determine sous le controle d'un promoteur d'adenovirus, vecteurs contenant cet adn recombinant, cellules eucaryotes transformees par cet adn recombinant, produits d'excretion de ces cellules transformees et leurs applications, notamment a la constitution de vaccins |
| WO1991011535A1 (en) * | 1990-01-30 | 1991-08-08 | Childrens Hospital Of Los Angeles | Inhibition of transcription by double-stranded oligonucleotides |
| WO1991018088A1 (en) * | 1990-05-23 | 1991-11-28 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | Adeno-associated virus (aav)-based eucaryotic vectors |
| FR2675803B1 (fr) * | 1991-04-25 | 1996-09-06 | Genset Sa | Oligonucleotides fermes, antisens et sens et leurs applications. |
| GB9114437D0 (en) * | 1991-07-03 | 1991-08-21 | Health Lab Service Board | Recombinant adenoviruses and the use thereof for detecting the presence in eukaryotic cells of the expression products of specific genes |
| FR2708283B1 (fr) * | 1994-01-14 | 1995-10-20 | Rhone Poulenc Rorer Sa | Compositions pharmaceutiques et leur utilisation, notamment pour le traitement des maladies neurodégénératives. |
-
1993
- 1993-06-30 FR FR9307962A patent/FR2707880B1/fr not_active Expired - Lifetime
-
1994
- 1994-06-27 EP EP94920987A patent/EP0707644B1/fr not_active Expired - Lifetime
- 1994-06-27 AT AT94920987T patent/ATE276360T1/de active
- 1994-06-27 DE DE69433996T patent/DE69433996T2/de not_active Expired - Lifetime
- 1994-06-27 KR KR1019950706050A patent/KR100517879B1/ko not_active Expired - Lifetime
- 1994-06-27 ES ES94920987T patent/ES2227528T3/es not_active Expired - Lifetime
- 1994-06-27 PT PT94920987T patent/PT707644E/pt unknown
- 1994-06-27 WO PCT/FR1994/000771 patent/WO1995001429A1/fr active IP Right Grant
- 1994-06-27 CA CA002166318A patent/CA2166318C/fr not_active Expired - Lifetime
- 1994-06-27 JP JP50330895A patent/JP3755825B2/ja not_active Expired - Lifetime
- 1994-06-27 AU AU71882/94A patent/AU696644B2/en not_active Expired
- 1994-06-27 EP EP04006618A patent/EP1454984A1/fr not_active Withdrawn
- 1994-06-27 US US08/569,149 patent/US6140112A/en not_active Expired - Lifetime
- 1994-06-27 DK DK94920987T patent/DK0707644T3/da active
-
1995
- 1995-12-01 NO NO19954888A patent/NO321455B1/no not_active IP Right Cessation
- 1995-12-29 FI FI956353A patent/FI120942B/sv not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69433996D1 (de) | 2004-10-21 |
| FR2707880A1 (fr) | 1995-01-27 |
| NO954888D0 (no) | 1995-12-01 |
| EP0707644A1 (fr) | 1996-04-24 |
| NO321455B1 (no) | 2006-05-15 |
| ATE276360T1 (de) | 2004-10-15 |
| AU7188294A (en) | 1995-01-24 |
| JPH08512043A (ja) | 1996-12-17 |
| DK0707644T3 (da) | 2005-01-17 |
| NO954888L (no) | 1995-12-01 |
| FR2707880B1 (fr) | 1995-10-06 |
| EP0707644B1 (fr) | 2004-09-15 |
| ES2227528T3 (es) | 2005-04-01 |
| JP3755825B2 (ja) | 2006-03-15 |
| KR960703432A (ko) | 1996-08-17 |
| WO1995001429A1 (fr) | 1995-01-12 |
| FI956353A0 (sv) | 1995-12-29 |
| AU696644B2 (en) | 1998-09-17 |
| FI120942B (sv) | 2010-05-14 |
| CA2166318C (fr) | 2009-02-10 |
| EP1454984A1 (fr) | 2004-09-08 |
| KR100517879B1 (ko) | 2005-12-16 |
| PT707644E (pt) | 2005-01-31 |
| CA2166318A1 (fr) | 1995-01-12 |
| US6140112A (en) | 2000-10-31 |
| DE69433996T2 (de) | 2005-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO943511L (no) | Farmasöytiske preparater og anvendelse derav | |
| EE9900075A (et) | 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks | |
| KR950703566A (ko) | 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof] | |
| FI945198L (sv) | Farmaceutiska och andra doseringsformer | |
| FI972366L (sv) | Lipopolyaminer som transfekterande ämnen och deras farmaceutisk användning | |
| CY2007001I1 (el) | Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη | |
| FI953838L (sv) | Imidazopyridiner och användning av dem vid behandling av gastrointestinala sjukdomar | |
| FI953479A0 (sv) | 1-arylpyrimidinderivat och farmaceutisk användning av dessa | |
| NO307925B1 (no) | Bicykliske aromatiske forbindelser, anvendelse derav, og farmasøytiske og kosmetiske preparater | |
| PT1083889E (pt) | Compostos de tetra-hidronaftaleno e sua utilizacao no tratamento de doencas neurodegenerativas | |
| FI20115742L (sv) | Användning av mometasonfuroat vid tillverkning av läkemedel | |
| FI944600L (sv) | Imidazol-4-ylpiperidinderivat, framställning av dessa och användning av dessa inom terapin | |
| EE9600139A (et) | Farmatseutilised preparaadid ja ravimid endoteelsete düsfunktsioonide vältimiseks ja raviks | |
| DE59607535D1 (de) | Kosmetische und/oder pharmazeutische zubereitungen | |
| FI954111L (sv) | Nya taxoider, deras framställning och dessa innehållande farmaceutiska preparat | |
| NO307510B1 (no) | Bicykliske aromatiske forbindelser, deres anvendelse og farmasøytiske og kosmetiske preparater derav | |
| DE59407193D1 (de) | Kosmetische und/oder pharmazeutische zubereitungen | |
| EE03312B1 (et) | Asendatud arüülalküültioalküültiopüridiinid Helicobacter bakterite tõrjeks, nende valmistamismeetod ja kasutamine ravimite valmistamiseks | |
| EE04371B1 (et) | Fenüülamidiini derivaadid, meetodid nende valmistamiseks ja nende kasutamine arstimitena | |
| FI961938L (sv) | Nya taxoider, deras framställning och dessa innehållande farmaceutiskaprodukter | |
| FI956353L (sv) | Farmaceutiska kompositioner och deras användning speciellt för behandling av neurodegenerativa sjukdomar | |
| DE59505714D1 (de) | Kosmetische und/oder pharmazeutische zubereitungen | |
| FI945694L (sv) | Sulfatsalt av substituerad triazol, dess farmaceutiska kompositioner och deras användning | |
| FI954138L (sv) | Hydroximetylfurazankarboxylsyraderivat och deras användning vid behandling av kardiovaskulära sjukdomar | |
| DE59410107D1 (de) | Chinoxaline und arzneimittel daraus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Transfer of assignment of patent |
Owner name: AVENTIS PHARMA S.A. |
|
| FG | Patent granted |
Ref document number: 120942 Country of ref document: FI |
|
| MA | Patent expired |